EXELIXIS, INC
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
Party shares are as of the party graph published ; a newer graph is being applied, and the totals are unchanged.
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under EXELIXIS, INC.
Showing the last published contribution snapshot. Newer source data is not included yet.
Party labels and allocations are as of the party graph published ; a newer graph is being applied.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Exelixis, Inc.. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 21–25 of 25 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · FAYETTEVILLE, AR, 72701 · EXELIXIS · Healthcare & Pharmaceuticals · COMMERCIAL · 1 transaction rows
DemocraticDerived from contributionsReported name + ZIP cluster; not a verified identity merge · SAN BRUNO, CA, 94066 · EXELIXIS, INC · Healthcare & Pharmaceuticals · DIRECTOR PROCUREMENT · 6 transaction rows
97% Democratic · 3% unclassifiedDerived from contributionsReported name + ZIP cluster; not a verified identity merge · SUNNYVALE, CA, 94086 · EXELIXIS · Healthcare & Pharmaceuticals · POLICY AND TRAINING MANAGER · 6 transaction rows
100% Democratic · 0% unclassifiedDerived from contributionsReported name + ZIP cluster; not a verified identity merge · ALAMEDA, CA, 94501 · EXELIXIS · Healthcare & Pharmaceuticals · PROJECT SPECIALIST · 4 transaction rows
DemocraticDerived from contributionsReported name + ZIP cluster; not a verified identity merge · SURPRISE, AZ, 85374 · EXELIXIS, INC. · Healthcare & Pharmaceuticals · LEGAL OPERATIONS LEADER · 1 transaction rows
DemocraticDerived from contributionsWhere the contributions went · 10 per page
Showing 1–10 of 30 · largest absolute amount first
House campaign committee · OAKLAND, CA · SIMON, LATEEFAH · U.S. House CA 12 · 15 transaction rows
DemocraticDerived from contributionsPAC (not qualified) · BATON ROUGE, LA · 3 transaction rows
93% Republican · 7% unclassifiedDerived from contributionsHouse campaign committee · NEWTONVILLE, MA · AUCHINCLOSS, JAKE · U.S. House MA 04 · 3 transaction rows
DemocraticDerived from contributionsHouse campaign committee · MONTCLAIR, NJ · GILL, BRENDAN W · U.S. House NJ 11 · 4 transaction rows
DemocraticDerived from contributionsSenate campaign committee · GREAT BEND, KS · MARSHALL, ROGER W · U.S. Senate KS 00 · 2 transaction rows
RepublicanDerived from contributionsHouse campaign committee · LONDON, KY · SMITH, KEVIN · U.S. House KY 05 · 1 transaction rows
RepublicanDerived from contributionsPAC (qualified) · NEW YORK, NY · 1 transaction rows
98% Democratic · 2% unclassifiedDerived from contributionsPAC (qualified) · WASHINGTON, DC · 5 transaction rows
DemocraticDerived from contributionsParty committee (qualified) · WASHINGTON, DC · 4 transaction rows
DemocraticDerived from contributionsHouse campaign committee · WASHINGTON, DC · DELAURO, ROSA L · U.S. House CT 03 · 1 transaction rows
DemocraticDerived from contributionsReported as EXELIXIS, INC
Industry classification summary
Exelixis, Inc. is a biopharmaceutical company specializing in oncology drug discovery and commercialization, as confirmed by official company materials and Forbes.
AI-generated classification based on saved sources
View source